We recognize that cancer therapies yield different outcomes for individual patients.
Our mission is to improve patient outcomes through
innovative macrocycle-mediated targeted delivery systems.
We are committed to developing versatile, multi-modal platforms that
enhance the effectiveness of targeted cancer therapies.

Co-founder, CEO & Board Director

Co-founder, CTO & Executive Chairman

Executive Vice Chairman
Capital Formation, Corporate Strategy, & Alliance Management

Co-founder, Director &
Head SAB

Independent Director
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.